This chapter provides information on the streamlining of Singapore’s public health system as an institutional foundation for the rise of Biopolis. The rapid introduction of a bioethics committee and op-out organs law installed international best practices for stem cell research and medical tourism. The timing also coincided with growing Asian concerns about biopiracy and interest in controlling the flow of samples overseas. Biopolis emerges as an Asian center that can mediate the need for international scientific protocols on the one hand, and the need to recruit samples and data from China and other Asian sites on the other. The chapter...